NBC Securities’s iShares US Pharmaceuticals ETF IHE Stock Holding History

NBC Securities’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$67.8K	Hold	685	–	–	﹤0.01%	1189
2026 Q1	$59.4K	Buy	685 +55	+9%	+$4.81K	﹤0.01%	1252
2025 Q4	$53.4K	Buy	630 +200	+47%	+$16K	﹤0.01%	1326
2025 Q3	$31.2K	Hold	430	–	–	﹤0.01%	1530
2025 Q2	$28K	Buy	430 +3	+0.7%	+$195	﹤0.01%	1559
2025 Q1	$30K	Buy	+427	New	+$29.7K	﹤0.01%	1328
2024 Q4	–	Sell	-449	Closed	-$31K	–	1646
2024 Q3	$31K	Buy	449 +110	+32%	+$7.67K	﹤0.01%	1328
2024 Q2	$22K	Hold	339	–	–	﹤0.01%	1419
2024 Q1	$23K	Sell	339 -12	-3%	-$793	﹤0.01%	1405
2023 Q4	$21K	Sell	351 -294	-46%	-$17.3K	﹤0.01%	1460
2023 Q3	$38K	Buy	+645	New	+$39.6K	﹤0.01%	1206

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

NBC Securities's IHE Position: Q2 2026 in Review

NBC Securities held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 685 shares worth $67.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1189.

NBC Securities first reported a position in IHE in Q3 2023 and has held it in 11 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

NBC Securities held 685 shares of iShares US Pharmaceuticals ETF worth $67.8K as of Q2 2026.
NBC Securities left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1189 holding.
NBC Securities first reported a position in iShares US Pharmaceuticals ETF in Q3 2023 and has held it in 11 quarters since.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.